Epithelix is partner of the FAIR consortium.
FAIR is an EU Horizon 2020 project that aims at evaluating the activation of the innate immune system in the airways. FAIR aims at providing an alternative adjunct strategy to standard of care antibiotics for treating pneumonia caused by antibiotic-resistant bacteria.
Epithelix is partner of the Organovir consortium.
OrganoVIR is a Horizon 2020 Marie Sklowdowska-Curie Actions Innovative Training Network (MSCA-ITN), that trains 15 Early Stage Researchers to lead innovation in the field of organoids for virology.
Organovir's mission is to transform the virology landscape and establish human organoids as superior models for virus research.
Epithelix is partner of the Onconanoscreen consortium.
Onconanoscreen is an interreg project linking Swiss and French research groups.
Onconanoscreen's mission is to develop an in vitro platform to screen nanotherapies against lung cancer.
OncoTheis is a biotech company dedicated to developing innovative bioengineered tissues and organoids for the many challenges in cancer research. OncoTheis is producing a new generation of integrated 3D in vitro models that combine both healthy and compromised tissues in order to accurately simulate the in vivo situation.
Ligue suisse contre la vivisection
The goal of "La ligue suisse contre la vivisection" is to fight, with all the possible legal means, against the practice of vivisection such as the use of animals for medical, scientific, military, industrial or commercial purposes, until the total abolition of such practices. It recognizes and financially helps the creation and development of alternative methods to animal testing.
In order to limit vivisection, Mr Egon Naef foundation helps researchers and scientists to develop alternative experimental methods to animal testing. Naef Foundation also encourages all researchers to use these alternative methods, especially the in vitro ones, within the framework of their research. Naef Foundation gives each year a prize to a scientist whose contributions were significant to the development of these alternative methods.
Pro anima / Ethic Science
Pro Anima website
Pro Anima is an apolitical and independent scientific board dedicated to develop human biomedical research by promoting alternatives to animal experimentation. Pro Anima has been active for more than 25 years using all the possible tools to raise awareness about animal testing and existing alternatives: social networks, stands, poster campaign petitions, medias, among other initiatives.
The European Society of Toxicology In Vitro is the leading organization in Europe that strengthens the scientific network of in vitro toxicologists and promotes in vitro toxicology, both scientifically and educationally in all countries of Europe.
Vitrocell systems offers customers from industry and research institutes new culture and exposure systems for in vitro studies on gases or complex mixtures. The VITROCELL modules adapted to MucilAir™ and SmallAir™ provide new possibilities for characterizing the effects of airborne substances such as gas, nanoparticles and complex mixtures.
Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation financially supports Epithelix research efforts to fight against COVID-19.
As principal investigator, Epithelix coordinates the research efforts of several BSL-3 laboratories to screen promising antivirals against SARS-CoV-2.
ATRA is a Swiss association founded in 1978 in Lugano.
Its goal is to fight, with all the possible legal means, against the practice of vivisection such as the use of animals for medical, scientific, military, industrial or commercial purposes, until the total abolition of such practices. It recognizes and financially helps the creation and development of alternative methods to animal testing.
AnimalFree Research website
For more than 40 years their commitment to the welfare and dignity of experimental animals constitues the basis for all the AnimalFree Research's activities. They are seeking dialog and cooperation, respect other positions but do not compromise their principles.
VirNext is a spin-off (EZUS Lyon) of Université Claude Bernard Lyon 1 (UCBL1) created within the VirPath laboratory.
Epithelix partners with VirNext to provide in vitro testing for SARS-CoV-2 infection using BSL-3 facility.
BioPark centralizes means and skills in the domain of life sciences.
Epithelix partners with BioPark to provide cutting edge chemical analysis (MALDI MS and MS/MS) on in vitro airway models.